The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-3-oxopropyl)quinazolin-4(3H)-one ID: ALA3092548
PubChem CID: 135676949
Max Phase: Preclinical
Molecular Formula: C20H19N3O2
Molecular Weight: 333.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCc1nc2ccccc2c(=O)[nH]1)N1CCc2ccccc2C1
Standard InChI: InChI=1S/C20H19N3O2/c24-19(23-12-11-14-5-1-2-6-15(14)13-23)10-9-18-21-17-8-4-3-7-16(17)20(25)22-18/h1-8H,9-13H2,(H,21,22,25)
Standard InChI Key: KNKPJIDSYXYYFM-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
20.7255 -19.2659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7244 -20.0854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4324 -20.4944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4306 -18.8570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1393 -19.2623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1426 -20.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8550 -20.4949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5686 -20.0816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5652 -19.2564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8482 -18.8445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8438 -18.0273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2774 -20.4883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9840 -20.0778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6928 -20.4844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3994 -20.0739 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6950 -21.3016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1041 -20.4826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1020 -18.8491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3913 -19.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8106 -19.2580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8067 -20.0730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5095 -20.4821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2167 -20.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2166 -19.2592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5133 -18.8537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
8 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
15 19 1 0
17 21 1 0
20 18 1 0
18 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.39Molecular Weight (Monoisotopic): 333.1477AlogP: 2.44#Rotatable Bonds: 3Polar Surface Area: 66.06Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.92CX Basic pKa: 5.40CX LogP: 2.00CX LogD: 2.02Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.80Np Likeness Score: -1.45
References 1. Lindgren AE, Karlberg T, Ekblad T, Spjut S, Thorsell AG, Andersson CD, Nhan TT, Hellsten V, Weigelt J, Linusson A, Schüler H, Elofsson M.. (2013) Chemical probes to study ADP-ribosylation: synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3/PARP3., 56 (23): [PMID:24188023 ] [10.1021/jm401394u ]